Life Fest 2014 Research Update Pt2
LRG Research Update presented by Dr. Anette Duensing, Dr. Jonathan Fletcher and Dr. Brian Rubin. Some statements in this video refer specifically to studies being discussed. View all of the Life Fest [...]
Liquid Biopsy Holds Promise for Precision Medicine
In a recent release from the Translational Genomics Research Institute (TGen), it was reported that researchers have discovered that by analyzing circulating tumor DNA (ctDNA) through liquid biopsy that a patient's cancer can be tracked [...]
ASCO Recommends Expanding Clinical Trials to Include More Older Adults
A recent call to action from ASCO (American Society of Clinical Oncology) published in the Journal of Clinical Oncology recommends expanding clinical trials to include more older adults. Given that greater than 60% of cancers in [...]
Cancer Cell Study from MDA Suggests New Approach
A recent study from MD Anderson Cancer Center provides insight into the ways that cancer cells metastasize. Scientists at The University of Texas MD Anderson Cancer Center have found that cancer cells traveling to other [...]
A Cure is Within Our Grasp
A Cure is Within Our Grasp! It is amazing what happens when you change what doesn't work - Our Life Raft Group Research Team is a great example of this
Update on LRG Research by Brian Rubin, M.D.
Here is a presentation from Life Fest 2012 by Brian Rubin, M.D. about the current state of the LRG Research team.
LRG Tissue Bank uncovers diagnosis issues in LatAm
A Life Raft Group meeting with Latin American representatives underscored barriers to the tissue bank program and proper diagnosis of GIST in the region while generating suggestions for ways of improving the system.
Cellular origin of GIST from the “good” cells’ perspective
The main functions of the gastrointestinal tract are to secrete digestive juices, break down food components, absorb nutrients, reclaim water and excrete waste, which are performed by the mucosal lining of the gut...
PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients
January 6th, 2011 - By Jerry Call, LRG Science CoordinatorThe first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled to open in [...]
Serum Imatinib (Gleevec) Levels Predict GIST Response
Here is a video on Serum Imatinib (Gleevec) Levels Predict GIST Response. George D. Demetri, M.D., discusses how Gleevec levels predict GIST response. Higher circulating levels of imatinib (Gleevec) correlated with better clinical responses in patients with [...]